Douglas Ward

Chief Executive Officer presso LUMOS DIAGNOSTICS HOLDINGS LIMITED

Patrimonio netto: 18 905 $ in data 31/03/2024

Health Technology

Consumer Services

Profilo

Douglas Ward is currently the Chief Executive Officer, Director, and Managing Director at Lumos Diagnostics Holdings Ltd.
He previously served as the Chief Executive Officer at Personal Genome Diagnostics, Inc. from 2016 to 2020.
Additionally, he held the position of Vice President of Strategy and Business Development at Hologic, Inc. Mr. Ward completed his undergraduate degree at Ohio Wesleyan University.

Partecipazioni note in società pubbliche

Società	Data	Numero di azioni	Valorizzazione	Data di valutazione
LUMOS DIAGNOSTICS HOLDINGS LTD. 0.10%	18/10/2023	475 000 ( 0.10% )	18 905 $	31/03/2024

Posizioni attive di Douglas Ward

Società	Posizione	Inizio
LUMOS DIAGNOSTICS HOLDINGS LIMITED	Chief Executive Officer	21/06/2022

Tutte le posizioni attive di Douglas Ward

Precedenti posizioni note di Douglas Ward

Società	Posizione	Fine
Personal Genome Diagnostics, Inc. Personal Genome Diagnostics, Inc. BiotechnologyHealth Technology Personal Genome Diagnostics, Inc. provides cancer genome analysis to help researchers identify cancer-related genetic changes. The firm's product PDGx develops liquid biopsy technology that uses patient-specific tumor alterations to create a simple blood test that enables tumor detection and monitoring. It provides cancer genome analyses to oncology researchers, drug developers, clinicians and patients. The company was founded by Luis A. Diaz Jr. and Victor Velculescu in 2010 and is headquartered in Baltimore, MD.	Chief Executive Officer	21/04/2020
HOLOGIC, INC.	Corporate Officer/Principal	-

Vedi nel dettaglio l'esperienza di Douglas Ward

Formazione di Douglas Ward

Ohio Wesleyan University

Undergraduate Degree

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Douglas Ward

Relazioni

Relazioni di 1° grado

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Società quotate in Borsa	2
HOLOGIC, INC.	Health Technology
LUMOS DIAGNOSTICS HOLDINGS LIMITED	Health Technology

Aziende private	1
Personal Genome Diagnostics, Inc. Personal Genome Diagnostics, Inc. BiotechnologyHealth Technology Personal Genome Diagnostics, Inc. provides cancer genome analysis to help researchers identify cancer-related genetic changes. The firm's product PDGx develops liquid biopsy technology that uses patient-specific tumor alterations to create a simple blood test that enables tumor detection and monitoring. It provides cancer genome analyses to oncology researchers, drug developers, clinicians and patients. The company was founded by Luis A. Diaz Jr. and Victor Velculescu in 2010 and is headquartered in Baltimore, MD.	Health Technology